Pharmaceutical scientists have just developed a new cold medicine, dubbed MiraQuil.
The scientists put the drug through extensive clinical trials. They found that of the participants who had a cold and then received the drug, 98% of them experienced no cold symptoms after a week!
Have the scientists made a good case that their drug is effective? Should they start selling the drug?
This section requires Javascript.
You are seeing this because something didn't load right. We suggest you, (a) try
refreshing the page, (b) enabling javascript if it is disabled on your browser and,
finally, (c)
loading the
non-javascript version of this page
. We're sorry about the hassle.
The most important piece of information missing from the clinical trials was the performance of the control group. Without knowing how cold-sufferers fare when they don't get the drug, it's not possible to know how effective the drug is.
It's pretty reasonable to assume that many cold symptoms will be gone after a week, even after not taking any medicine. It's possible that the control group had an equally "miraculous" result. However, without seeing the data, it's not possible to know.